Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms (2017)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-016-1750-1
PubMed Identifier: 28143564
Publication URI: http://europepmc.org/abstract/MED/28143564
Type: Journal Article/Review
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215